Targeting colony-stimulating factor 1 receptor (CSF1R) significantly reduces M2 TAM infiltration and increases CD8 T cell infiltration in CRC tumor tissue, effectively inhibiting tumor growth and metastasis, and improving the response to immunotherapy [[47], [48], [49]]. This evidence concerns the gene CSF1R and colorectal carcinoma.